Amputation as a marker of the quality of foot care in diabetes

Strategic targets for the management of foot ulcers focus on reducing the incidence of amputation. While data on the incidence of amputation can be obtained relatively easily, the figures require very careful interpretation. Variation in the definition of amputation, population selection and the choice of numerator and denominator make comparisons difficult. Major and minor amputation have to be distinguished as they are undertaken for different reasons and are associated with different costs and functional implications. Many factors influence the decision of whether or not to remove a limb. In addition to disease severity, co-morbidities, and social and individual patient factors, many aspects of the structure of care services affect this decision, including access to primary care, quality of primary care, delays in referral, availability and quality of specialist resources, and prevailing medical opinion. It follows that a high incidence of amputation can reflect a higher disease prevalence, late referral, limited resources, or a particularly interventionist approach by a specialist team. Conversely, a low incidence of amputation can indicate a lower disease prevalence or severity, good management of diabetes in primary and secondary care, or a particularly conservative approach by an expert team. An inappropriately conservative approach could conceivably enhance suffering by condemning a person to months of incapacity before they die with an unhealed ulcer. The reported annual incidence of major amputation in industrialised countries ranges from 0.06 to 3.83 per 103 people at risk. Some centres have documented that the incidence is falling, but this is often from a baseline value that was unusually high. Other centres have reported that the incidence has not changed. The ultimate target is to achieve not only a decrease in incidence, but also a low overall incidence. This must be accompanied by improvements in morbidity, mortality, and patient function and mood.

[1]  M. Sherman Acute and chronic osteomyelitis. , 1949, The Surgical clinics of North America.

[2]  P. Home,et al.  A Survey of Lower Limb Amputation in Diabetic Patients , 1992, Diabetic medicine : a journal of the British Diabetic Association.

[3]  M. Hunink,et al.  The use of angioplasty, bypass surgery, and amputation in the management of peripheral vascular disease. , 1992, The New England journal of medicine.

[4]  Jennifer S. Lee,et al.  Lower-Extremity Amputation: Incidence, Risk Factors, and Mortality in the Oklahoma Indian Diabetes Study , 1993, Diabetes.

[5]  Trends in arterial reconstruction, angioplasty and amputation. , 1994, Health trends.

[6]  T. Schroeder,et al.  Epidemiology of leg amputation: The influence of vascular surgery , 1994, The British journal of surgery.

[7]  C. Agardh,et al.  Decreasing Incidence of Major Amputation in Diabetic Patients: a Consequence of a Multidisciplinary Foot Care Team Approach? , 1995, Diabetic medicine : a journal of the British Diabetic Association.

[8]  W. Houtum,et al.  The Costs of Diabetes‐related Lower Extremity Amputations in the Netherlands , 1995, Diabetic medicine : a journal of the British Diabetic Association.

[9]  W. Houtum,et al.  Regional variation in the incidence of diabetes-related amputations in The Netherlands. , 1996, Diabetes research and clinical practice.

[10]  L. Lavery,et al.  Variation in the Incidence and Proportion of Diabetes-Related Amputations in Minorities , 1996, Diabetes Care.

[11]  L. Lavery,et al.  Outcomes associated with diabetes‐related amputations in the Netherlands and in the state of California, USA , 1996, Journal of internal medicine.

[12]  L. Ebskov,et al.  Major lower limb amputation in diabetic patients: development during 1982 to 1993 , 1996, Diabetologia.

[13]  A. Calle-Pascual,et al.  Nontraumatic lower extremity amputations in diabetic and non-diabetic subjects in Madrid, Spain. , 1997, Diabetes & metabolism.

[14]  L. Lavery,et al.  Methodological issues affect variability in reported incidence of lower extremity amputations due to diabetes. , 1997, Diabetes research and clinical practice.

[15]  David G Armstrong,et al.  Validation of a Diabetic Wound Classification System: The contribution of depth, infection, and ischemia to risk of amputation , 1998, Diabetes Care.

[16]  G. Reiber,et al.  The burden of diabetic foot ulcers. , 1998, American journal of surgery.

[17]  Failure of reducing lower extremity amputations in diabetic patients: results of two subsequent population based surveys 1990 and 1995 in Germany. , 1998, VASA. Zeitschrift fur Gefasskrankheiten.

[18]  G. Leese,et al.  Diabetes and Lower-Limb Amputations in the Community: A retrospective cohort study , 1998, Diabetes Care.

[19]  R. Mazze,et al.  Reducing lower-extremity amputations due to diabetes. Application of the staged diabetes management approach in a primary care setting. , 1998, The Journal of family practice.

[20]  C. Phillips,et al.  Diabetes mellitus and nontraumatic lower extremity amputation in black and white Americans: the National Health and Nutrition Examination Survey Epidemiologic Follow-up Study, 1971-1992. , 1999, Archives of internal medicine.

[21]  H. Alaranta,et al.  Epidemiology of lower limb amputees in Southern Finland in 1995 and trends since 1984 , 1999, Prosthetics and orthotics international.

[22]  C. Phillips,et al.  Diabetes Mellitus and Nontraumatic Lower Extremity Amputation in Black and White Americans , 1999 .

[23]  M. Mangan,et al.  Project LEAP of New Jersey: lower extremity amputation prevention in persons with type 2 diabetes. , 1999, The American journal of managed care.

[24]  E H Wagner,et al.  Incidence, outcomes, and cost of foot ulcers in patients with diabetes. , 1999, Diabetes care.

[25]  Consensus development conference on diabetic foot wound care. 7-8 April 1999, Boston, MA. American Diabetes Association , 1999, Advances in wound care : the journal for prevention and healing.

[26]  D. Smith,et al.  Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers. , 1999, Diabetes care.

[27]  J. Feinglass,et al.  Rates of lower-extremity amputation and arterial reconstruction in the United States, 1979 to 1996. , 1999, American journal of public health.

[28]  P. Holstein,et al.  Decreasing incidence of major amputations in people with diabetes , 2000, Diabetologia.

[29]  R. Horswell,et al.  Effectiveness of a comprehensive diabetes lower-extremity amputation prevention program in a predominantly low-income African-American population. , 2000, Diabetes care.

[30]  N. Unwin,et al.  Epidemiology of lower extremity amputation in centres in Europe, North America and East Asia , 2000, The British journal of surgery.

[31]  C. Payne,et al.  Diabetes‐related lower‐limb amputations in Australia , 2000, The Medical journal of Australia.

[32]  J. Czerniecki,et al.  Trends in lower limb amputation in the Veterans Health Administration, 1989-1998. , 2000, Journal of rehabilitation research and development.

[33]  A. Eskelinen,et al.  Changing pattern of major lower limb amputations in Seinäjoki Central Hospital 1997-2000. , 2001, Annales chirurgiae et gynaecologiae.

[34]  P. Bennett,et al.  Follow-up of the WHO multinational study of vascular disease in diabetes: general description and morbidity , 2001, Diabetologia.

[35]  H. Rønningen,et al.  Lower limb amputations: Registration of all lower limb amputations performed at the University Hospital of Trondheim, Norway, 1994–1997 , 2001, Prosthetics and orthotics international.

[36]  G. Reiber,et al.  Geographic variation of lower-extremity major amputation in individuals with and without diabetes in the Medicare population. , 2001, Diabetes care.

[37]  R. LaPorte,et al.  Capture-recapture method to estimate lower extremity amputation rates in Rio de Janeiro, Brazil. , 2001, Revista panamericana de salud publica = Pan American journal of public health.

[38]  Reiber Ge,et al.  Hospital discharge rates for nontraumatic lower extremity amputation by diabetes status--United States, 1997. , 2001, MMWR. Morbidity and mortality weekly report.

[39]  H. Keen The WHO multinational study of vascular disease in diabetes , 2001, Diabetologia.

[40]  M. Airey,et al.  Variation in clinical decision making is a partial explanation for geographical variation in lower extremity amputation rates , 2001, The British journal of surgery.

[41]  N. Chaturvedi,et al.  Risk factors, ethnic differences and mortality associated with lower-extremity gangrene and amputation in diabetes. The WHO multinational study of vascular disease in diabetes , 2001, Diabetologia.

[42]  A. Calle-Pascual,et al.  Epidemiology of nontraumatic lower-extremity amputation in area 7, Madrid, between 1989 and 1999: a population-based study. , 2001, Diabetes care.

[43]  G. Giani,et al.  Unchanged incidence of lower-limb amputations in a German City, 1990-1998. , 2001, Diabetes care.

[44]  N. Chaturvedi,et al.  Risk of diabetes‐related amputation in South Asians vs. Europeans in the UK , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[45]  Diabetes-related lower extremity amputations in the community: a study based on hospital discharge diagnoses. , 2002, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[46]  W. Henderson,et al.  Lower Extremity Nontraumatic Amputation Among Veterans With Peripheral Arterial Disease: Is Race an Independent Factor? , 2002, Medical care.

[47]  W. Payne,et al.  Decreasing amputation rates in patients with diabetes mellitus. An outcome study. , 2002, Journal of the American Podiatric Medical Association.

[48]  N. Chaturvedi,et al.  Ethnicity and risk of diabetes-related lower extremity amputation: a population-based, case-control study of African Caribbeans and Europeans in the United kingdom. , 2002, Archives of internal medicine.

[49]  W. Chie,et al.  Rates and characteristics of lower limb amputations in Taiwan, 1997 , 2002, Prosthetics and orthotics international.

[50]  R Legood,et al.  The impact of diabetes‐related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65) , 2003, Diabetic medicine : a journal of the British Diabetic Association.

[51]  W. Jeffcoate,et al.  Diabetic foot ulcers , 2003, The Lancet.

[52]  Ronald Horswell,et al.  The impact of a staged management approach to diabetes foot care in the Louisiana public hospital system. , 2003, The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society.

[53]  Lower extremity amputation episodes among persons with diabetes--New Mexico, 2000. , 2003, MMWR. Morbidity and mortality weekly report.

[54]  G. Reiber,et al.  Effects of ethnicity and nephropathy on lower-extremity amputation risk among diabetic veterans. , 2003, Diabetes care.

[55]  Xianglin L. Du,et al.  Lower extremity amputations in diabetic Mexican American elders: incidence, prevalence and correlates. , 2003, Journal of diabetes and its complications.

[56]  G. Gill,et al.  Amputation and Mortality in New-Onset Diabetic Foot Ulcers Stratified by Etiology , 2003 .

[57]  David G Armstrong,et al.  Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort. , 2003, Diabetes care.

[58]  J. Rauwerda,et al.  Reduction in diabetes-related lower-extremity amputations in The Netherlands: 1991-2000. , 2004, Diabetes care.

[59]  N. Schaper,et al.  Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies , 2004, Diabetes/Metabolism Research Reviews.

[60]  W. Jeffcoate,et al.  Controversies in diagnosing and managing osteomyelitis of the foot in diabetes. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[61]  W. Jeffcoate,et al.  Validation of a system of foot ulcer classification in diabetes mellitus , 2004, Diabetic medicine : a journal of the British Diabetic Association.